Log in

Relevant bibliographies by topics / Renal toxicity / Journal articles

To see the other types of publications on this topic, follow the link: Renal toxicity.

Journal articles on the topic 'Renal toxicity'

Author: Grafiati

Published: 4 June 2021

Last updated: 26 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Renal toxicity.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Lindsley, Carol B., and Bradley A. Warady. "Renal Toxicity." Clinical Pediatrics 29, no. 1 (1990): 10–13. http://dx.doi.org/10.1177/000992289002900101.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Mrvos, Rita, Tara L. Pummer, and Edward P. Krenzelok. "Amoxicillin Renal Toxicity." Pediatric Emergency Care 29, no. 5 (2013): 641–43. http://dx.doi.org/10.1097/pec.0b013e31828e9e78.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Gentz, Brenda A., and T. Philip Malan. "Renal Toxicity with Sevoflurane." Drugs 61, no. 15 (2001): 2155–62. http://dx.doi.org/10.2165/00003495-200161150-00001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Farrugia, Emanuel, and Timothy S. Larson. "Drug-induced renal toxicity." Postgraduate Medicine 90, no. 2 (1991): 241–48. http://dx.doi.org/10.1080/00325481.1991.11701021.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Crowell, J. A. "Resveratrol-Associated Renal Toxicity." Toxicological Sciences 82, no. 2 (2004): 614–19. http://dx.doi.org/10.1093/toxsci/kfh263.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Labaye, Jacques, Damien Sarret, Christan Duvic, et al. "Renal toxicity of Oxaliplatin." Nephrology Dialysis Transplantation 20, no. 6 (2005): 1275–76. http://dx.doi.org/10.1093/ndt/gfh826.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

K., Sara. "PPI INDUCED RENAL TOXICITY." INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES o6, no. 02 (2019): 4321–26. https://doi.org/10.5281/zenodo.2574961.

Full text

Abstract:

<em>PPIs are mostly used drugs in many prescriptions along with drugs for other co-morbidities and also used for long time periods and as OTC drugs (medication). These drugs on prolong use causes renal toxicity in many cases by affecting glomerular filtration and also through several cases like increase in pH, gastroenteritis, hyperplasia, hypertrophy, hypergastrinemia, hyperchlorhydria, and effect on mitochondrial cells. The unrequited actions by PPIs also can appear in paediatrics along with adults. In this paper we will review about brief information regarding pharmacokinetics and pharmacod

APA, Harvard, Vancouver, ISO, and other styles

8

Perazella, Mark A. "Renal Vulnerability to Drug Toxicity." Clinical Journal of the American Society of Nephrology 4, no. 7 (2009): 1275–83. http://dx.doi.org/10.2215/cjn.02050309.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Alan Selçuk, Nalan, and Türkay Toklu. "Renal Toxicity After Radionuclide Therapy." Nuclear Medicine Seminars 5, no. 3 (2019): 207–12. http://dx.doi.org/10.4274/nts.galenos.2019.0029.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Gonçalves, MD, Ferraz. "Morphine toxicity in renal failure." Journal of Opioid Management 2, no. 3 (2006): 174. http://dx.doi.org/10.5055/jom.2006.0027.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

JONES, PAULA G. "Acyclovir: Neurologic and Renal Toxicity." Annals of Internal Medicine 104, no. 6 (1986): 892. http://dx.doi.org/10.7326/0003-4819-104-6-892_2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

George, Charles R. P. "Renal aspects of lithium toxicity." Medical Journal of Australia 150, no. 6 (1989): 291–92. http://dx.doi.org/10.5694/j.1326-5377.1989.tb136485.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Lakhal, Karim, Stephan Ehrmann, and Vincent Robert-Edan. "Iodinated Contrast Medium Renal Toxicity." Critical Care Medicine 45, no. 7 (2017): e745-e746. http://dx.doi.org/10.1097/ccm.0000000000002430.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Subedi, Rogin, Ryan K. Dean, Arbind Chaudhary, and Tamas Szombathy. "Flecainide toxicity in renal failure." Baylor University Medical Center Proceedings 31, no. 3 (2018): 328–30. http://dx.doi.org/10.1080/08998280.2018.1463042.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Lieben, Liesbet. "Lipid toxicity drives renal disease." Nature Reviews Nephrology 13, no. 4 (2017): 194. http://dx.doi.org/10.1038/nrneph.2017.22.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

John, R., and A. M. Herzenberg. "Renal toxicity of therapeutic drugs." Journal of Clinical Pathology 62, no. 6 (2009): 505–15. http://dx.doi.org/10.1136/jcp.2008.058271.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Stewart, R. R. C., R. J. Winney, and J. D. Cash. "Renal Toxicity of Intravenous Immunoglobulin." Vox Sanguinis 65, no. 3 (1993): 244. http://dx.doi.org/10.1159/000462433.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Pettersson, Göran, Rob Towart, Derek Grant, Kerstin Thyberg, and Klaes Golman. "The Rabbit Renal Toxicity Test." Academic Radiology 9, no. 1 (2002): S62—S64. http://dx.doi.org/10.1016/s1076-6332(03)80398-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Jonassen, Julie A., Yasuo Kohjimoto, Cheryl R. Scheid, and Madelyn Schmidt. "Oxalate toxicity in renal cells." Urological Research 33, no. 5 (2005): 329–39. http://dx.doi.org/10.1007/s00240-005-0485-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Lambert, Bieke, Markus Cybulla, Stefan M. Weiner, et al. "Renal Toxicity after Radionuclide Therapy." Radiation Research 161, no. 5 (2004): 607–11. http://dx.doi.org/10.1667/rr3105.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Stewart, R. R. C., R. J. Winney, and J. D. Cash. "Renal Toxicity of Intravenous Immunoglobulin." Vox Sanguinis 65, no. 3 (1993): 244. http://dx.doi.org/10.1111/j.1423-0410.1993.tb02159.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Olyaei, Ali J., Angelo M. deMattos, and William M. Bennett. "Renal toxicity of protease inhibitors." Current Opinion in Nephrology and Hypertension 9, no. 5 (2000): 473–76. http://dx.doi.org/10.1097/00041552-200009000-00003.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Borch, Richard F., and Thomas J. Montine. "Renal toxicity of antineoplastic agents." Toxicology Letters 53, no. 1-2 (1990): 93–96. http://dx.doi.org/10.1016/0378-4274(90)90100-z.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Kelly, Ronan J., Bertrand Billemont, and Olivier Rixe. "Renal toxicity of targeted therapies." Targeted Oncology 4, no. 2 (2009): 121–33. http://dx.doi.org/10.1007/s11523-009-0109-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Rosansky, Steven J. "Verapamil Toxicity and Renal Failure." Archives of Internal Medicine 152, no. 9 (1992): 1925. http://dx.doi.org/10.1001/archinte.1992.00400210145027.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Rosansky, S. J. "Verapamil toxicity and renal failure." Archives of Internal Medicine 152, no. 9 (1992): 1925b—1925. http://dx.doi.org/10.1001/archinte.152.9.1925b.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Lyon, CC, and JH Turney. "PSEUDOEPHEDRINE TOXICITY IN RENAL FAILURE." International Journal of Clinical Practice 50, no. 7 (1996): 396–97. http://dx.doi.org/10.1111/j.1742-1241.1996.tb09584.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Hadi, Haydar F. "Comparison Between Two NSAIDs (Non selective & selective COX-2 Inhibitor) According to their Renal Toxicity on Elderly People." Al Mustansiriyah Journal of Pharmaceutical Sciences 4, no. 1 (2007): 125–36. http://dx.doi.org/10.32947/ajps.v4i1.387.

Full text

Abstract:

The nonsteroidal anti-inflammatory drugs (NSAIDs) are widly used all over the world for different rheumatic musculoskeletal disorders. Like any other chemical compounds, they have different side effects like renal toxicity that becomes very serious when used for long time especially from elderly people whose already have a reduced renal function or those This with renal or cardiac problems that may increase the incidence of such toxicity. study focusing on this point, by comparing between 2 NSAIDs, a non selective-COX inhibitor (Indomethacin) and selective COX-2 inhibitor (Meloxicam) acc

APA, Harvard, Vancouver, ISO, and other styles

29

Kohler, James J., Seyed H. Hosseini, Amy Hoying-Brandt, et al. "Tenofovir renal toxicity targets mitochondria of renal proximal tubules." Laboratory Investigation 89, no. 5 (2009): 513–19. http://dx.doi.org/10.1038/labinvest.2009.14.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Jaimes, Edgar A. "Renal Toxicity of Systemic Therapy for Renal Cell Carcinoma." Seminars in Nephrology 40, no. 1 (2020): 49–58. http://dx.doi.org/10.1016/j.semnephrol.2019.12.006.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Kus, Tulay, and Gokmen Aktas. "Durable response after interruption of nivolumab in patients with metastatic renal cell carcinoma: Is renal toxicity a marker to predict the benefit of nivolumab?" Journal of Oncology Pharmacy Practice 26, no. 4 (2019): 1000–1004. http://dx.doi.org/10.1177/1078155219877923.

Full text

Abstract:

Introduction Nivolumab is a human IgG4 programmed death-1 immune checkpoint inhibitor antibody. Immune-related toxicity may be associated with higher response even after interruption of nivolumab. Case report We reported a case diagnosed with metastatic clear cell renal cell carcinoma and treated with nivolumab as fourth-line therapy. Although nivolumab treatment was stopped after two cycles due to grade 3 renal toxicity, progression-free survival rates of 11 months, that is quite a long time for fourth-line treatment of renal cell carcinoma was observed. Management and outcome Therefore, we s

APA, Harvard, Vancouver, ISO, and other styles

32

Pinzani, V�ronique, Fran�oise Bressolle, Inger Johanne Haug, Marc Galtier, Jean Pierre Blayac, and Pierre Balm�s. "Cisplatin-induced renal toxicity and toxicity-modulating strategies: a review." Cancer Chemotherapy and Pharmacology 35, no. 1 (1994): 1–9. http://dx.doi.org/10.1007/s002800050185.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Pinzani, V�ronique, Fran�oise Bressolle, Inger Johanne Haug, Marc Galtier, Jean Pierre Blayac, and Pierre Balm�s. "Cisplatin-induced renal toxicity and toxicity-modulating strategies: a review." Cancer Chemotherapy and Pharmacology 35, no. 1 (1994): 1–9. http://dx.doi.org/10.1007/bf00686277.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Robinson, D., and CA McCoy. "Ethylene glycol toxicity." Critical Care Nurse 9, no. 6 (1989): 70–74. http://dx.doi.org/10.4037/ccn1989.9.6.70.

Full text

Abstract:

Ingestion of ethylene glycol is a rare occurrence, but it is an attractive agent for intoxication and suicide. Treatment is aimed at rapid excretion of the EG, prevention of the formation of metabolites, and the prevention and treatment of renal failure. Prior to discharge, Mr K revealed that he had drunk the antifreeze because he was despondent about his work situation. He had a short, but intensive trajectory that followed the three-system-involvement classic to EG poisoning, with the renal system most severely affected. Mr K was discharged from the hospital one week after admission and refe

APA, Harvard, Vancouver, ISO, and other styles

35

Zrelli, M., E. Bergaoui, N. Staali, K. Souabni, and W. Melki. "Lithium-Renal and brain induced toxicity." European Psychiatry 65, S1 (2022): S711. http://dx.doi.org/10.1192/j.eurpsy.2022.1832.

Full text

Abstract:

Introduction Lithium can induce renal and neurotoxic effects, particularly if it is combined with a neuroleptic or if there is an intercurrent condition. The neurological sequelae may be irreversible. Objectives To show the renal and neurotoxic effects of lithium and the risk of its association with haloperidol. Methods A case of irreversible lithium neurotoxicity wih renal sequelae. Results This case report is about a 57-year-old patient with a bipolar disorder type 1. She was well stabilized on lithium.On December 2020, the patient had an increased level of creatinine, therefore her medicati

APA, Harvard, Vancouver, ISO, and other styles

36

Righini, Matteo, Veronica Mollica, Alessandro Rizzo, Gaetano La Manna, and Francesco Massari. "Renal Toxicities in Cancer Patients Receiving Immune-Checkpoint Inhibitors: A Meta-Analysis." Journal of Clinical Medicine 11, no. 15 (2022): 4373. http://dx.doi.org/10.3390/jcm11154373.

Full text

Abstract:

Aim: We performed a meta-analysis of the available clinical trials of immune-checkpoint inhibitors to assess risk differences and relative risks of renal toxicity. Methods: 17 randomized phase III studies were selected, including 10,252 patients. Results: The administration of immune-checkpoint inhibitors resulted in an overall low-grade, high-grade and all-grade renal toxicity Risk Difference of: 0.746% (95% CI 0.629% to 1.15%, p < 0.001—random), 0.61% (95% CI, 0.292–0.929%, p < 0.001—fixed) and 1.2% (95% CI, 0.601–1.85%—random), respectively. The pooled Relative Risk of low-grade, high

APA, Harvard, Vancouver, ISO, and other styles

37

Ali, Harzhin Hiwa, and Tavga Ahmed Aziz. "Renal Toxicity of Tenofovir: Narrative Review." Al-Rafidain Journal of Medical Sciences ( ISSN: 2789-3219 ) 2 (April 9, 2022): 40–50. http://dx.doi.org/10.54133/ajms.v2i.63.

Full text

Abstract:

Tenofovir is a reverse-transcriptase inhibitor based on acyclic nucleotide analogs. Tenofovir is a drug that is often used in treating HIV infection and has also been approved for treating infection by the hepatitis B virus. Despite the fact that its renal safety has been demonstrated in cell culture and clinical trials, clinical use and in vivo animal studies have shown its association with a low, but important, risk of kidney injury. Tenofovir accumulation in these mitochondria-rich cells is explained by proximal tubular cell secretion. Proximal tubular cell dysfunction is a symptom of Tenof

APA, Harvard, Vancouver, ISO, and other styles

38

&NA;. "Renal toxicity reports with zoledronic acid." Reactions Weekly &NA;, no. 1173 (2007): 1. http://dx.doi.org/10.2165/00128415-200711730-00002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

&NA;. "Prevention of drug-induced renal toxicity." Reactions Weekly &NA;, no. 380 (1991): 3. http://dx.doi.org/10.2165/00128415-199103800-00005.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

AOYAGI, Kazumasa, and Mitsuharu NARITA. "Active oxygen toxicity in renal diseases." Japanese Journal of Medicine 29, no. 6 (1990): 681–82. http://dx.doi.org/10.2169/internalmedicine1962.29.681.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Calza, Leonardo. "Renal Toxicity Associated With Antiretroviral Therapy." HIV Clinical Trials 13, no. 4 (2012): 189–211. http://dx.doi.org/10.1310/hct1304-189.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Woodward, CLN, AM Hall, IG Williams, et al. "Tenofovir-associated renal and bone toxicity." HIV Medicine 10, no. 8 (2009): 482–87. http://dx.doi.org/10.1111/j.1468-1293.2009.00716.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Diamond, Gary L., and Rudolfs K. Zalups. "Understanding Renal Toxicity of Heavy Metals." Toxicologic Pathology 26, no. 1 (1998): 92–103. http://dx.doi.org/10.1177/019262339802600111.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Borg, Martin, Timothy Hughes, Noemi Horvath, Michael Rice, and Anthony C. Thomas. "Renal toxicity after total body irradiation." International Journal of Radiation Oncology*Biology*Physics 54, no. 4 (2002): 1165–73. http://dx.doi.org/10.1016/s0360-3016(02)03039-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Thiebault, Celine, Marie Carriere, and Barbara Gouget. "Toxicity of uranium on renal cells." Toxicology Letters 172 (October 2007): S57. http://dx.doi.org/10.1016/j.toxlet.2007.05.172.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Borg, M. B., T. Hughes, and C. Tilley. "Renal toxicity after total body irradiation." European Journal of Cancer 37 (April 2001): S202. http://dx.doi.org/10.1016/s0959-8049(01)81230-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Hayman, Suzanne R., Nelson Leung, Joseph P. Grande, and Vesna D. Garovic. "VEGF Inhibition, Hypertension, and Renal Toxicity." Current Oncology Reports 14, no. 4 (2012): 285–94. http://dx.doi.org/10.1007/s11912-012-0242-z.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Kyo, Masahiro, Michael J. Mihatsch, Fred Gudat, Peter Dalquen, Beat Huser, and Gilbert Thiel. "Renal graft rejection or cyclosporin toxicity?" Transplant International 5, no. 2 (1992): 71–76. http://dx.doi.org/10.1007/bf00339219.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Deconinck, Eric, and Jean-Yves Cahn. "Renal toxicity after bone marrow transplantation." International Journal of Radiation Oncology*Biology*Physics 58, no. 3 (2004): 661–62. http://dx.doi.org/10.1016/j.ijrobp.2003.08.016.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Rodriguez-Nóvoa, Sonia, Elena Alvarez, Pablo Labarga, and Vincent Soriano. "Renal toxicity associated with tenofovir use." Expert Opinion on Drug Safety 9, no. 4 (2010): 545–59. http://dx.doi.org/10.1517/14740331003627458.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!